Gautam Kollu photo Illumina logo

Gautam Kollu

Head of Market Development, Illumina (USA)


Gautam Kollu leads worldwide market development efforts for Illumina’s Reproductive & Genetic Health business. His teams are responsible for identifying and nurturing new markets for the application of NGS in diagnostics such as non-invasive prenatal testing, pre-implantation genetic screening and diagnosis, and pre-conception and newborn screening. Gautam is accomplished in the launch and commercialization of innovative healthcare technologies, having held leadership and executive roles in driving several successful products including Herceptin, Avastin, Kadcyla, Cometriq, Panorama, verifi and VeriSeq. He currently chairs the Global Fertility Alliance and tweets from @gautamkollu. He received an MBA from The Wharton School and a B. Tech. in Chemical Engineering from IIT Bombay.

Gautam Kollu logo

Gautam Kollu

Head of Market Development, Illumina (USA)


Illumina logo

Gautam Kollu leads worldwide market development efforts for Illumina’s Reproductive & Genetic Health business. His teams are responsible for identifying and nurturing new markets for the application of NGS in diagnostics such as non-invasive prenatal testing, pre-implantation genetic screening and diagnosis, and pre-conception and newborn screening. Gautam is accomplished in the launch and commercialization of innovative healthcare technologies, having held leadership and executive roles in driving several successful products including Herceptin, Avastin, Kadcyla, Cometriq, Panorama, verifi and VeriSeq. He currently chairs the Global Fertility Alliance and tweets from @gautamkollu. He received an MBA from The Wharton School and a B. Tech. in Chemical Engineering from IIT Bombay.


Why WIN